Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Noritaka Kawada"'
Autor:
Yoshihiko Fujino, Noritaka Kawada, Katsukiyo Ito, Hiroshi Katsura, Hajime Maeda, Kensuke Mitsumoto, Takashi Uzu
Publikováno v:
Renal Replacement Therapy, Vol 4, Iss 1, Pp 1-4 (2018)
Abstract Background Pleuroperitoneal leak is an uncommon but significant complication of peritoneal dialysis. Although the exact pathogenesis of pleuroperitoneal communication remains unclear, the pressure gradient between the thorax and abdominal ca
Externí odkaz:
https://doaj.org/article/556f6dca9c134abf9a388ebad0aa4600
Autor:
Katsukiyo Ito, Yoshihiko Fujino, Hajime Maeda, Takashi Uzu, Hiroshi Katsura, Kensuke Mitsumoto, Noritaka Kawada
Publikováno v:
Renal Replacement Therapy, Vol 4, Iss 1, Pp 1-4 (2018)
Background Pleuroperitoneal leak is an uncommon but significant complication of peritoneal dialysis. Although the exact pathogenesis of pleuroperitoneal communication remains unclear, the pressure gradient between the thorax and abdominal cavity has
Publikováno v:
Journal of the Renin-Angiotensin-Aldosterone System, Vol 16 (2015)
Hypothesis: This study determined the parameters for predicting the clinical effects of eplerenone (Ep) add-on therapy on blood pressure (BP) and proteinuria in patients taking angiotensin-converting enzyme inhibitors (ACEis) or angiotensin II type I
Autor:
Toshiki Moriyama, Hiromi Rakugi, Shiro Takahara, Noritaka Kawada, Harumi Kitamura, Hidetoshi Tsuda, Jun-ya Kaimori, Yoshitaka Isaka
Publikováno v:
Biochemical and Biophysical Research Communications. 427:266-272
Febuxostat is a novel selective inhibitor of xanthine oxidase (XO), approved for treating hyperuricemia. XO inhibits the generation of uric acid (UA) as well as the resulting generation of superoxide. During renal ischemia-reperfusion (I/R) injury, t
Autor:
Isao Matsui, Christopher S. Wilcox, Enyu Imai, Noritaka Kawada, Ryohei Yamamoto, Harumi Kitamura, Yoshitaka Isaka, Hiromi Rakugi, Yoshiyuki Furumatsu, Yoshitsugu Takabatake, Yasuyuki Nagasawa, Toshiki Moriyama
Publikováno v:
Clinical and Experimental Nephrology. 16:25-29
The antipyretic and analgesic actions of nonsteroidal anti-inflammatory drugs (NSAIDs) are caused by the inhibition of prostaglandin E(2) (PGE(2)), thromboxane A(2) and prostacyclin (PGI(2)) production. Accumulating evidence suggests that the inhibit
Autor:
Yoshitsugu Obi, Maki Shinzawa, Yasuhiko Sakata, Yasuyuki Nagasawa, Hiromi Rakugi, Harumi Kitamura, Tomonori Kimura, Isao Matsui, Kazunori Inoue, Noritaka Kawada, Takayuki Hamono, Yoshitaka Isaka
Publikováno v:
Clinical and Experimental Nephrology. 15:854-860
Patients with chronic kidney disease (CKD) still frequently experience cardiovascular events despite recent progress in treatment. We examined whether nicorandil, a hybrid nitrate and adenosine triphosphate-sensitive potassium channel opener, could i
Autor:
Noritaka Kawada, Hirotsugu Iwatani, Kenichiro Iio, Enyu Imai, Hiromi Rakugi, Yoshitaka Isaka, Yoshitsugu Takabatake, Yasuyuki Nagasawa, Yoshiyuki Furumatsu, Tatsuya Shoji, Ryohei Yamamoto, Isao Matsui
Publikováno v:
Nephrology Dialysis Transplantation. 25:1930-1935
Background. The quality of dialysis care provided by specialists is expected to be superior to that by nonspecialists. However, little is known about the actual effect of specialist care on long-term prognosis in dialysis patients. We sought to deter
Autor:
Enyu Imai, Yoshitsugu Takabatake, Yasuyuki Nagasawa, Yukito Kokado, Naotsugu Ichimaru, Ryoichi Imamura, Shiro Takahara, Hiromi Rakugi, Isao Matsui, Toshiki Moriyama, Noritaka Kawada, Yasuyuki Kojima, Yoshitaka Isaka
Publikováno v:
Clinical and Experimental Nephrology. 13:355-360
Anemia is a common complication in posttransplant patients (posttransplant anemia: PTA). We tested the hypothesis that targeting hemoglobin (Hb) over 13.3 g/dl by administration of recombinant human erythropoietin (rHuEPO-ad) has positive impact on q
Autor:
Takayuki Hamano, Isao Matsui, Takahito Ito, Yasuyuki Nagasawa, Masaru Horio, Hirotsugu Iwatani, Yoshitaka Isaka, Hirotaka Tanaka, Noritaka Kawada, Enyu Imai
Publikováno v:
Clinical and Experimental Nephrology. 13:61-65
Olmesartan medoxomil is a new angiotensin-2 receptor blocker (ARB). Its pharmacokinetics in hemodialysis patients has not been investigated. We evaluated the pharmacokinetics of olmesartan medoxomil in six patients on maintained hemodialysis. We divi
Autor:
Christopher S. Wilcox, Noritaka Kawada, Paul Modlinger, Kinjal Patel, William J. Welch, Margarida Mendonca, Kathryn Dennehy, Shakil Aslam
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 293:H2644-H2649
Angiotensin (ANG) II activating type 1 receptors (AT1Rs) enhances superoxide anion (O2•−) and arachidonate (AA) formation. AA is metabolized by cyclooxygenases (COXs) to PGH2, which is metabolized by thromboxane (Tx)A2synthase to TxA2or oxidized